Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAPI PET-CT in Resectable Biliary Tract Cancers
NCT06355427Phase 3Recruiting
- Start
- Nov 2024
- Primary completion
- Sep 2027
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial. Primary endpoint: Diagnostic accuracy of [18F]F-FAPI PET-CT at 6 months. Started Nov 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06355427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355427.